GB201107755D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB201107755D0 GB201107755D0 GBGB1107755.9A GB201107755A GB201107755D0 GB 201107755 D0 GB201107755 D0 GB 201107755D0 GB 201107755 A GB201107755 A GB 201107755A GB 201107755 D0 GB201107755 D0 GB 201107755D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- compounds
- acid addition
- phenylethyi
- pyrrolo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940098779 methanesulfonic acid Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to certain acid addition salts of 4-methyl-1-(2-phenylethyI)-8- phenoxy-2,3-dihydro-1H-pyrrolo[3,2-c]-quinoline, including the methane sulfonic acid addition salt thereof, to a process for the preparation of such compounds, and to the use of such compounds for the treatment of microbial infections.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1107755.9A GB201107755D0 (en) | 2011-05-10 | 2011-05-10 | Novel compounds |
| PCT/GB2012/051013 WO2012153130A1 (en) | 2011-05-10 | 2012-05-09 | Salts of 4 -ethyl-1-(2 - phenylethyl) - 8 -phenoxy - 2, 3 - dihydro - 1h - pyrrolo [3, 2 -c] quinoline and their use for treating infections |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1107755.9A GB201107755D0 (en) | 2011-05-10 | 2011-05-10 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201107755D0 true GB201107755D0 (en) | 2011-06-22 |
Family
ID=44243865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1107755.9A Ceased GB201107755D0 (en) | 2011-05-10 | 2011-05-10 | Novel compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201107755D0 (en) |
| WO (1) | WO2012153130A1 (en) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0727979B1 (en) | 1993-10-22 | 2001-06-27 | Smithkline Beecham Corporation | Novel composition |
| US6974585B2 (en) | 2001-08-01 | 2005-12-13 | Medlogic Global Limited | Durable multi-component antibiotic formulation for topical use |
| KR20070091613A (en) | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | Topical pharmaceutical compositions containing anti-acne compounds and antibiotic compounds |
| GB0522715D0 (en) | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| GB0709513D0 (en) | 2007-05-17 | 2007-06-27 | Helperby Therapeutics Ltd | Topical formulations |
| US20100068516A1 (en) | 2007-02-26 | 2010-03-18 | Joon-Young Yoon | Thermoplastic fiber with excellent durability and fabric comprising the same |
| GB201013207D0 (en) * | 2010-08-05 | 2010-09-22 | Helperby Therapeutics Ltd | Novel combination |
| GB201015079D0 (en) * | 2010-09-10 | 2010-10-27 | Helperby Therapeutics Ltd | Novel use |
| CN103249402A (en) * | 2010-10-08 | 2013-08-14 | 赫尔普百治疗有限公司 | Novel composition |
-
2011
- 2011-05-10 GB GBGB1107755.9A patent/GB201107755D0/en not_active Ceased
-
2012
- 2012-05-09 WO PCT/GB2012/051013 patent/WO2012153130A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012153130A1 (en) | 2012-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500872A1 (en) | Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| EA201491149A1 (en) | PYRAZOLOPIRIDINE DERIVATIVES, METHODS OF THEIR PRODUCTION AND THEIR THERAPEUTIC USE | |
| TN2014000138A1 (en) | Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases. | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| PH12015501609A1 (en) | Phenicol antibacterials | |
| MY183398A (en) | Derivatives of azaindazole or diazaindazole type for treating pain | |
| NZ711343A (en) | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation | |
| GEP201706690B (en) | Novel process for making compounds for use in treatment of cancer | |
| SG10201900541QA (en) | Derivatives of xanthone compounds | |
| WO2012104823A3 (en) | Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases | |
| MX2013000009A (en) | Process for the preparation of the l-arginine salt of perindopril. | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| HK1201067A1 (en) | Sialic acid analogs | |
| GB201107985D0 (en) | Process | |
| PH12015500061A1 (en) | Method for preparing substituted triazolopyridines | |
| AU2012307449A8 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
| GB201107755D0 (en) | Novel compounds | |
| MX366887B (en) | Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-met hyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation. | |
| TN2013000146A1 (en) | Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| UA71418U (en) | 5,7-DIMETHYL-6-PHENYLAZO-3H-THIAZOLO[4,5-b]PYRIDINE-2-ONE EXHIBITING ANTIEXUDATIVE ACTION | |
| UA71417U (en) | Potash salt of 5,7-dimethyl-6-phenylazo-3h-thiazolo[4,5-b]pyridine-2-oneexhibiting antiexudative action | |
| PL396871A1 (en) | Naphthalene-1,4-diphosphonic acid, process for the preparation of naphthalene-1,4-diphosphonic acid and the use of naphthalene-1,4-diphosphonic acid | |
| UA67859U (en) | 3,4-dimethyl-1-ethylcyclohex-3-ene carboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |